Background
Agitation is a common, challenging symptom affecting large numbers of people with dementia and impacting on quality of life (QoL). There is an urgent need for evidence-based, cost-effective psychosocial interventions to improve these outcomes, particularly in the absence of safe, effective pharmacological therapies. This study aimed to evaluate the efficacy of a person-centred care and psychosocial intervention incorporating an antipsychotic review, WHELD, on QoL, agitation, and antipsychotic use in people with dementia living in nursing homes, and to determine its cost.
Reference:
Clive Ballard, Anne Corbett, Martin Orrell,Gareth Williams,Esme Moniz-Cook,Renee Romeo,Bob Woods,Lucy Garrod,Ingelin Testad,Barbara Woodward-Carlton,Jennifer Wenborn,Martin Knapp,Jane Fossey, February 6, 20182,Pmed, doi.org/10.1371/journal.pmed.1002500